We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Crystallization Aids Study of Neuron Receptors

By Biotechdaily staff writers
Posted on 09 Jun 2002
Researchers using protein crystallization techniques have found that perturbations at the molecular structure level govern desensitization of neurons and reduced response to neurotransmitters. More...
This work, which helps to explain how experimental, memory-enhancing drugs affect the brain on a molecular level, was published in the May 16, 2002, issue of Nature.

"Learning how neurons respond to neurotransmitters is important not only to understanding basic brain functioning, but also may one day lead to new insights into a variety of new therapies,” said Duane Alexander, Director of the National Institute of Child Health and Human Development (Bethesda MD, USA), which conducted the research.

The GLUR2 AMPA-sensitive glutamate receptor, one of the ligand-gated ion channels, was the subject of the study. Investigators took advantage of the fact that after activation many ligand-gated ion channels enter a desensitized state in which the neurotransmitter remains bound but the ion channel is closed. One part of the glutamate receptor was isolated by biochemical methods, and its structure was examined at the atomic level. Researchers then designed altered receptors and determined their atomic structures as well. By observing how experimental drugs interacted with both mutant and normal receptors, they hoped to gain more insights into how the drugs interact with the receptor and into the process of desensitization.

Results showed that receptor activation involves conformational changes within each receptor subunit that produce an increase in the separation of portions of the receptor that are linked to the ion channel. Desensitization occurs through rearrangements that dislocate the ligand-binding core from the ion channel gate.



Related Links:
National Institute of Child Health and Human Development

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Hematology Consumables
Bioblood Devices
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.